Ignite Creation Date:
2025-12-24 @ 12:48 PM
Ignite Modification Date:
2026-01-23 @ 5:12 PM
Study NCT ID:
NCT01021761
Status:
COMPLETED
Last Update Posted:
2011-08-31
First Post:
2009-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Sponsor:
Frank A. Bucci, Jr., M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2009 0199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |